BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23831864)

  • 1. Electrophysiological correlates of hyperalgesic priming in vitro and in vivo.
    Hendrich J; Alvarez P; Joseph EK; Chen X; Bogen O; Levine JD
    Pain; 2013 Oct; 154(10):2207-2215. PubMed ID: 23831864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid-Induced Hyperalgesic Priming in Single Nociceptors.
    Khomula EV; Araldi D; Bonet IJM; Levine JD
    J Neurosci; 2021 Jan; 41(1):31-46. PubMed ID: 33203743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptor subpopulations involved in hyperalgesic priming.
    Ferrari LF; Bogen O; Levine JD
    Neuroscience; 2010 Feb; 165(3):896-901. PubMed ID: 19931357
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Khomula EV; Araldi D; Levine JD
    J Neurosci; 2019 Sep; 39(36):7061-7073. PubMed ID: 31300521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperalgesic priming is restricted to isolectin B4-positive nociceptors.
    Joseph EK; Levine JD
    Neuroscience; 2010 Aug; 169(1):431-5. PubMed ID: 20457222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Morphine Produces Dose-dependent Nociceptor-mediated Biphasic Changes in Nociceptive Threshold and Neuroplasticity.
    Ferrari LF; Araldi D; Bogen O; Green PG; Levine JD
    Neuroscience; 2019 Feb; 398():64-75. PubMed ID: 30529265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.
    Araldi D; Ferrari LF; Levine JD
    Pain; 2016 Aug; 157(8):1773-1782. PubMed ID: 27075428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine acts in vitro to directly prime nociceptors.
    Khomula EV; Levine JD
    Mol Pain; 2024; 20():17448069241260348. PubMed ID: 38828868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct terminal and cell body mechanisms in the nociceptor mediate hyperalgesic priming.
    Ferrari LF; Araldi D; Levine JD
    J Neurosci; 2015 Apr; 35(15):6107-16. PubMed ID: 25878283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.
    Araldi D; Ferrari LF; Levine JD
    J Neurosci; 2015 Sep; 35(36):12502-17. PubMed ID: 26354917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl Induces Rapid Onset Hyperalgesic Priming: Type I at Peripheral and Type II at Central Nociceptor Terminals.
    Araldi D; Khomula EV; Ferrari LF; Levine JD
    J Neurosci; 2018 Feb; 38(9):2226-2245. PubMed ID: 29431655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat.
    Parada CA; Yeh JJ; Joseph EK; Levine JD
    Eur J Neurosci; 2003 May; 17(9):1847-52. PubMed ID: 12752784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming.
    Araldi D; Bogen O; Green PG; Levine JD
    J Neurosci; 2019 Aug; 39(33):6414-6424. PubMed ID: 31209174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical sensitization of cutaneous C-fiber nociceptors by prostaglandin E2 in the rat.
    Chen X; Tanner K; Levine JD
    Neurosci Lett; 1999 May; 267(2):105-8. PubMed ID: 10400223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accounting for the delay in the transition from acute to chronic pain: axonal and nuclear mechanisms.
    Ferrari LF; Bogen O; Reichling DB; Levine JD
    J Neurosci; 2015 Jan; 35(2):495-507. PubMed ID: 25589745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral prostaglandin E2 prolongs the sensitization of nociceptive dorsal root ganglion neurons possibly by facilitating the synthesis and anterograde axonal trafficking of EP4 receptors.
    St-Jacques B; Ma W
    Exp Neurol; 2014 Nov; 261():354-66. PubMed ID: 24910202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperalgesic priming (type II) induced by repeated opioid exposure: maintenance mechanisms.
    Araldi D; Ferrari LF; Levine JD
    Pain; 2017 Jul; 158(7):1204-1216. PubMed ID: 28306605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma membrane mechanisms in a preclinical rat model of chronic pain.
    Ferrari LF; Levine JD
    J Pain; 2015 Jan; 16(1):60-6. PubMed ID: 25451625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide signaling in pain and nociceptor sensitization in the rat.
    Aley KO; McCarter G; Levine JD
    J Neurosci; 1998 Sep; 18(17):7008-14. PubMed ID: 9712669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of a novel nociceptor autocrine mechanism in chronic pain.
    Ferrari LF; Levine E; Levine JD
    Eur J Neurosci; 2013 May; 37(10):1705-13. PubMed ID: 23379641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.